BIOMAT Database Logo BIOMAT Database Logo

Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts. 1993

M L Barr, and D J Cohen, and A I Benvenisty, and M Hardy, and K Reemtsma, and E A Rose, and C C Marboe, and V D'Agati, and N Suciu-Foca, and E Reed
Department of Surgery, College of Physicians & Surgeons, Columbia University, New York, New York 10032.

Study of anti-HLA antibodies in a population of 238 primary renal and 199 primary heart allograft recipients showed significant association between development of anti-HLA antibodies and that of chronic allograft rejection. The 5-year renal allograft survival was 70% in recipients without antibodies and 53% in recipients who developed anti-HLA alloantibodies during the first year following transplantation. Heart allograft survival at 5 years was 91% in patients without and 78% in patients with antibodies during the first 12 months posttransplantation. Development of antibodies is associated with acute rejection episodes and probably with the release of soluble HLA antigens.

UI MeSH Term Description Entries
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006681 HLA-D Antigens Human immune-response or Class II antigens found mainly, but not exclusively, on B-lymphocytes and produced from genes of the HLA-D locus. They are extremely polymorphic families of glycopeptides, each consisting of two chains, alpha and beta. This group of antigens includes the -DR, -DQ and -DP designations, of which HLA-DR is most studied; some of these glycoproteins are associated with certain diseases, possibly of immune etiology. Antigens, HLA-D,Class II Human Antigens,HLA-Dw Antigens,Human Class II Antigens,Ia-Like Antigens, Human,Immune Response-Associated Antigens, Human,Immune-Associated Antigens, Human,Immune-Response Antigens, Human,HLA-D,HLA-Dw,Immune Response Associated Antigens, Human,Antigens, HLA D,Antigens, HLA-Dw,Antigens, Human Ia-Like,Antigens, Human Immune-Associated,Antigens, Human Immune-Response,HLA D Antigens,HLA Dw Antigens,Human Ia-Like Antigens,Human Immune-Associated Antigens,Human Immune-Response Antigens,Ia Like Antigens, Human,Immune Associated Antigens, Human,Immune Response Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000888 Antibodies, Anti-Idiotypic Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies. Anti-Antibodies,Anti-Idiotype Antibodies,Antibodies, Internal Image,Antigamma Globulin Antibodies,Antiglobulins,Anti Antibodies,Anti-gamma Globulin Antibodies,Anti Idiotype Antibodies,Anti gamma Globulin Antibodies,Anti-Idiotypic Antibodies,Antibodies, Anti,Antibodies, Anti Idiotypic,Antibodies, Anti-Idiotype,Antibodies, Anti-gamma Globulin,Antibodies, Antigamma Globulin,Globulin Antibodies, Anti-gamma,Globulin Antibodies, Antigamma,Image Antibodies, Internal,Internal Image Antibodies
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic

Related Publications

M L Barr, and D J Cohen, and A I Benvenisty, and M Hardy, and K Reemtsma, and E A Rose, and C C Marboe, and V D'Agati, and N Suciu-Foca, and E Reed
Anti-HLA and anti-MICA antibodies in liver transplant recipients: effect on long-term graft survival.
January 2013, Clinical & developmental immunology,
M L Barr, and D J Cohen, and A I Benvenisty, and M Hardy, and K Reemtsma, and E A Rose, and C C Marboe, and V D'Agati, and N Suciu-Foca, and E Reed
Long-term survival of kidney allografts.
January 1987, Clinical transplants,
M L Barr, and D J Cohen, and A I Benvenisty, and M Hardy, and K Reemtsma, and E A Rose, and C C Marboe, and V D'Agati, and N Suciu-Foca, and E Reed
Anti-HLA antibodies and heart allograft survival.
February 1989, Transplantation proceedings,
M L Barr, and D J Cohen, and A I Benvenisty, and M Hardy, and K Reemtsma, and E A Rose, and C C Marboe, and V D'Agati, and N Suciu-Foca, and E Reed
The lack of long-term detrimental effects on liver allografts caused by donor-specific anti-HLA antibodies.
May 1993, Transplantation,
M L Barr, and D J Cohen, and A I Benvenisty, and M Hardy, and K Reemtsma, and E A Rose, and C C Marboe, and V D'Agati, and N Suciu-Foca, and E Reed
The impact of HLA-A matching on long-term survival of renal allografts.
March 1996, Transplantation,
M L Barr, and D J Cohen, and A I Benvenisty, and M Hardy, and K Reemtsma, and E A Rose, and C C Marboe, and V D'Agati, and N Suciu-Foca, and E Reed
Complement-binding anti-HLA antibodies and kidney-allograft survival.
September 2013, The New England journal of medicine,
M L Barr, and D J Cohen, and A I Benvenisty, and M Hardy, and K Reemtsma, and E A Rose, and C C Marboe, and V D'Agati, and N Suciu-Foca, and E Reed
Preexistent anti-HLA-DR antibodies and kidney graft survival.
March 1979, Transplantation proceedings,
M L Barr, and D J Cohen, and A I Benvenisty, and M Hardy, and K Reemtsma, and E A Rose, and C C Marboe, and V D'Agati, and N Suciu-Foca, and E Reed
Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts.
September 1989, The New England journal of medicine,
M L Barr, and D J Cohen, and A I Benvenisty, and M Hardy, and K Reemtsma, and E A Rose, and C C Marboe, and V D'Agati, and N Suciu-Foca, and E Reed
Beneficial effect of bilateral native nephrectomy on long-term survival of living related kidney allografts.
February 1989, Transplantation proceedings,
M L Barr, and D J Cohen, and A I Benvenisty, and M Hardy, and K Reemtsma, and E A Rose, and C C Marboe, and V D'Agati, and N Suciu-Foca, and E Reed
Complement Binding Anti-HLA Antibodies and the Survival of Kidney Transplantation.
March 2023, Journal of clinical medicine,
Copied contents to your clipboard!